PATENT CLAIM ANALYSIS

Application Number: 16128830
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2018-12
Patent Classification: ["424", "190100"]

Abstract:
This invention is directed to composition, vaccines, tools and methods in the treatment and prevention of  Bordetella pertussis . In particular, the invention is directed to a three-pronged approach that involves removal of the nonessential vaccine components, use of a nondenatured, genetically detoxified mutant, and adding virulence factors.

Claim (Index 13):
The method of  claim 1 , wherein the lipooligosaccharide comprises a synthetic or a deamination product obtained or derived from  B. pertussis.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.44737
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15131674', '14896222', '14800126', '15264890', '09855754']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7646927940758058
- 35 USC 102 Novelty (BERT): 0.6047327770613867
- Combined Prediction Score: 0.7486967923743639
- Mean Citation Score: 358.212618
- Max Citation Score: 600.4172
- Similarity Product: 449.8146284944296

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test